The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
// Anna Chen 1, 2 , Christina S.F. Wong 3 , Mira C.P. Liu 1 , Colin M. House 1 , Jaclyn Sceneay 3 , David D. Bowtell 1, 2, 4, 5 , Erik W. Thompson 6, 7, 8 , Andreas Möller 3 1 Cancer Genomics and Genetics Laboratory, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne 3002, Australia 2 Department of Pathology, The University of Melbourne, Parkville 3010, Australia 3 Tumour Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston 4006, Australia 4 Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville 3010, Australia 5 Department of Biochemistry, The University of Melbourne, Parkville 3010, Australia 6 The University of Melbourne Department of Surgery, St Vincent’s Hospital, Fitzroy 3065, Australia 7 St Vincent’s Institute of Medical Research, Fitzroy 3065, Australia 8 Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Kelvin Grove 4000, Australia Correspondence to: Andreas Möller, e-mail: andreas.moller@qimr.edu.au Received: August 06, 2014 Accepted: November 04, 2014 Published: November 18, 2014 ABSTRACT Elucidating the mechanisms that underlie metastasis is of paramount importance to understanding tumor progression and to the development of novel therapeutics. Epithelial to Mesenchymal Transition (EMT) plays a vital role in tumor cell dissemination and is regulated by a core cassette of transcription factors. Despite recent advances, the molecular pathways that regulate the EMT program have not yet been fully delineated. We show that Siah ubiquitin ligases regulate Zeb1 protein, a key EMT transcription factor. The induction of EMT in breast cancer cells leads to the down-regulation of Siah, while the loss of Siah induces a mesenchymal phenotype, concurrent with an up-regulation of Zeb1. Overexpression of Siah in vitro mediates Zeb1 degradation, which can be blocked with a Siah peptide inhibitor. Thus, this work demonstrates that Siah is a novel regulator of EMT. This work is the first to identify a mechanism of post-translational regulation of the key Epithelial to Mesenchymal Transition transcription factor Zeb1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 1×
“Aberrant Zeb1 expression has been described in a number of other cancers, including colorectal cancer, metastatic lung cancer and aggressive uterine cancer [8, 9].”
BackgroundTGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · cited 1×
“While post-translational regulatory mechanisms involving ubiquitination and proteasomal degradation of Snail, Slug, Twist and Zeb2 have been described, the regulation of Zeb1 protein abundance is currently unknown [12–15].”
BackgroundSun, R. C., & Denko, N. C. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.022 · Cited by 344
Cited by
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Context-dependent EMT programs in cancer metastasis
Aiello, N. M., & Kang, Y. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181827 · Cited by 584
Wu, Y., Yang, X., Chen, Z., Tian, L., Jiang, G., Chen, F., Li, J., An, P., Lu, L., Luo, N., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1014-2 · Cited by 392
Metadata
- Authors
- Chen, A., Wong, C. S. F., Liu, M. C. P., House, C. M., Sceneay, J., Bowtell, D. D., Thompson, E. W., & Möller, A.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-12-18
- Volume
- 6
- Issue
- 2
- Pages
- 862-873
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2134287597
- Cited by
- 68
- References
- 4
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer. https://app.cochat.ai/papers/10.18632/oncotarget.2696
- The paper
- Chen, A., Wong, C. S. F., Liu, M. C. P., House, C. M., Sceneay, J., Bowtell, D. D., Thompson, E. W., & Möller, A. (2015). The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer. Oncotarget. https://doi.org/10.18632/oncotarget.2696
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.